Perceptive Advisors owns 20.75% of Penwest Pharmaceuticals

By Lisa Kerner

Charlotte, N.C., July 17 - A group of Penwest Pharmaceuticals Co. shareholders led by Perceptive Advisors LLC reported a 20.75% stake in the company in a schedule 13D filed with the Securities and Exchange Commission.

The investors bought 4,108,180 shares of the company's stock between Jan. 23 and March 20 priced from $3.08 to $7.50 each, the filing stated.

Perceptive Advisors and its affiliates beneficially own approximately 6.56 million shares of the Danbury, Conn., pharmaceutical products company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.